Mangalam Drugs & Organics (BOM:532637) ROCE % : 11.33% (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mangalam Drugs & Organics's annualized ROCE % for the quarter that ended in Sep. 2024 was 11.33%.

Mangalam Drugs & Organics ROCE % Historical Data

The historical data trend for Mangalam Drugs & Organics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics ROCE % Chart

Mangalam Drugs & Organics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

10.55

33.19

19.77

-0.37

Mangalam Drugs & Organics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-19.55	7.81	10.31	10.22	11.33

Mangalam Drugs & Organics ROCE % Calculation

Mangalam Drugs & Organics's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-6.645	/	( ( (3596.288 - 1653.575)	+	(3337 - 1640.611) )	/ 2 )
	=	-6.645	/	( (1942.713	+	1696.389)	/ 2 )
	=	-6.645	/	1819.551
	=	-0.37 %

Mangalam Drugs & Organics's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	194.62	/	( ( (0 - 0)	+	(3641.107 - 1923.711) )	/ 1 )
	=	194.62	/	( ( 0	+	1717.396 )	/ 1 )
	=	194.62	/	1717.396
	=	11.33 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Mangalam Drugs & Organics (BOM:532637) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mangalam Drugs & Organics ROCE % Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » ROCE %

Traded in Other Exchanges

MANGALAM:India

Address

P. D'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001

Website

https://www.mangalamdrugs.com

Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines